Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT06304636 · TERMINATED

Trial details

NCT number: NCT06304636
Sponsor: Cartesian Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Multiple Myeloma Relapsed Multiple Myeloma

Start date: 2024-06-19
Primary completion: 2025-04-14
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.